GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Innovation1 Biotech Inc (OTCPK:IVBT) » Definitions » EV-to-Revenue

Innovation1 Biotech (Innovation1 Biotech) EV-to-Revenue : (As of Jun. 06, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Innovation1 Biotech EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Innovation1 Biotech's enterprise value is $0.21 Mil. Innovation1 Biotech's Revenue for the trailing twelve months (TTM) ended in Aug. 2023 was $0.00 Mil. Therefore, Innovation1 Biotech's EV-to-Revenue for today is .

The historical rank and industry rank for Innovation1 Biotech's EV-to-Revenue or its related term are showing as below:

During the past 9 years, the highest EV-to-Revenue of Innovation1 Biotech was 25631.05. The lowest was 8.72. And the median was 73.56.

IVBT's EV-to-Revenue is not ranked *
in the Diversified Financial Services industry.
Industry Median: 3.79
* Ranked among companies with meaningful EV-to-Revenue only.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-06), Innovation1 Biotech's stock price is $0.0008. Innovation1 Biotech's Revenue per Share for the trailing twelve months (TTM) ended in Aug. 2023 was $0.00. Therefore, Innovation1 Biotech's PS Ratio for today is .


Innovation1 Biotech EV-to-Revenue Historical Data

The historical data trend for Innovation1 Biotech's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innovation1 Biotech EV-to-Revenue Chart

Innovation1 Biotech Annual Data
Trend Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only 11.45 1,228.70 197.29 - -

Innovation1 Biotech Quarterly Data
Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Innovation1 Biotech's EV-to-Revenue

For the Shell Companies subindustry, Innovation1 Biotech's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Innovation1 Biotech's EV-to-Revenue Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Innovation1 Biotech's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Innovation1 Biotech's EV-to-Revenue falls into.



Innovation1 Biotech EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Innovation1 Biotech's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=0.205/0
=

Innovation1 Biotech's current Enterprise Value is $0.21 Mil.
Innovation1 Biotech's Revenue for the trailing twelve months (TTM) ended in Aug. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Innovation1 Biotech  (OTCPK:IVBT) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Innovation1 Biotech's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.0008/0
=

Innovation1 Biotech's share price for today is $0.0008.
Innovation1 Biotech's Revenue per Share for the trailing twelve months (TTM) ended in Aug. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Innovation1 Biotech EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Innovation1 Biotech's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Innovation1 Biotech (Innovation1 Biotech) Business Description

Traded in Other Exchanges
N/A
Address
40 Wall Street, Suite 2701, New York, NY, USA, 10005
Innovation1 Biotech Inc is a shell company.
Executives
Grays Peak Llc 10 percent owner 8 THE GREEN, STE. A, DOVER DE 19803
Timothy Orr director, 10 percent owner, officer: President 4010 TANAGER LANE, #A, MEAD WA 99021
Darren Long director, 10 percent owner, officer: CEO & Secretary 4010 TANAGER LANE, #A, MEAD WA 99021
Brian Martinho director, 10 percent owner, officer: Treasurer 4010 EAST TANAGER LANE, MEAD WA 99021